最近の記事
- 2026/02/27
- AI プレシジョン患者がん移植ゼブラフィッシュシステム(PDXZ)の革新性
- 2026/02/12
- 『ゼブラフィッシュ創薬®』生体 MieKomachi１０５種類
- 2026/02/02
- 「ゼブラフィッシュ創薬®」PDXZの展開
- 2026/02/02
- 患者がん移植ゼブラフィッシュシステム(PDXZ)による 創薬スクリーニングと臨床治験応用
- 2026/01/21
- AI プレシジョン患者がん移植ゼブラフィッシュ(PDXZ)セミナー
- 2026/01/20
- 『ゼブラフィッシュ創薬®』生体 MieKomachi
- 2025/12/26
- 260121 AIプレシジョンPDXZセミナーのご案内
- 2025/12/11
- PDXZは、創薬スクリーニングを革新する。
- 2025/12/10
- 2026年1月21日(水)AIプレシジョンPDXZzoomセミナー
- 2025/12/09
- PDXZの放射線増感作試験 (Radio-sensitization)
| 2024/07/01 |
|
personalized cancer treatment using patient-derived xenografts zebrafish model
Personalized cancer treatment using patient-derived xenografts in zebrafish is a rapidly developing area of research with the potential to revolutionize cancer care. Here's a breakdown of the process and its key aspects:
The Process:
Tumor Sample Collection: A small sample of a patient's tumor is extracted through a biopsy or surgery.
Zebrafish Embryo Preparation: Zebrafish embryos are bred and raised in controlled laboratory settings.
Tumor Transplantation: Tiny pieces of the patient's tumor are implanted into a specific location within the zebrafish embryo, often the yolk sac.
Drug Testing: Different potential cancer drugs are administered to the zebrafish containing the patient's tumor cells.
Tumor Monitoring: Researchers closely observe the growth and response of the tumors in the zebrafish embryos over time.
Drug Response Evaluation: Based on the tumor growth patterns, scientists can identify the most effective drugs for the patient's specific cancer.
Advantages:
Personalized Medicine: Drugs are selected based on the patient's tumor's unique response, potentially leading to more effective treatment.
Rapid Assessment: Zebrafish embryos develop quickly, allowing for faster evaluation of drug efficacy compared to traditional methods.
Cost-Effectiveness: Using zebrafish embryos is a relatively inexpensive way to test potential drugs.
Ethical Considerations: Zebrafish are invertebrates and likely don't experience pain, addressing ethical concerns present with some animal models.
Limitations:
Species Differences: While zebrafish share genetic similarities with humans, there might be discrepancies in drug metabolism and tumor behavior.
Tumor Complexity: Zebrafish embryos might not fully represent the intricate nature of human tumors, especially advanced or metastatic cancers.
Clinical Translation: Further research is needed to confirm the findings from zebrafish studies and translate them into successful clinical treatment strategies.
Overall, this approach holds promise for:
Developing individualized treatment plans: Tailoring treatment based on a patient's specific cancer can potentially improve outcomes.
Identifying new and more effective cancer drugs: Faster drug testing allows for quicker development of new treatment options.
関連リンク
関連ファイル
- personalized cancer treatment using patient-derived xenografts zebrafish model
- Novel immunologic tolerance of human cancercell xenotransplants in zebrafish
関連画像
